Chemoradiotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer

Dun-Chang Mo

Shang-Xiao Huang

Dun-Chang Mo, MD; Shang-Xiao Huang, MD; Jian-Feng Huang, MD; Xiu-Juan Liang, MD; and Han-Lei Wang, MD, Radiotherapy Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, China

Jian-Feng Huang

Dun-Chang Mo, MD; Shang-Xiao Huang, MD; Jian-Feng Huang, MD; Xiu-Juan Liang, MD; and Han-Lei Wang, MD, Radiotherapy Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, China

Xiu-Juan Liang

Dun-Chang Mo, MD; Shang-Xiao Huang, MD; Jian-Feng Huang, MD; Xiu-Juan Liang, MD; and Han-Lei Wang, MD, Radiotherapy Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, China

Han-Lei Wang

Dun-Chang Mo, MD; Shang-Xiao Huang, MD; Jian-Feng Huang, MD; Xiu-Juan Liang, MD; and Han-Lei Wang, MD, Radiotherapy Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, China